The human body and its parts are widely perceived as matters beyond commercial usage. This belief is codified in several national and European documents. This so-called ‘no-property rule’ is held to be the default position across the countries of the European Union. However, a closer look at the most pertinent national and European documents, and also current practices in the field, reveals a gradual model of commercialisation of human tissue. In particular, we will argue that the ban on commercialisation of body material is not as strict as it may appear at first sight, leaving room for the commercial practice of tissue procurement and transfer. We argue for more transparent information for patients and tissue donors, an intensified ethical debate on commercialisation practices, and a critical review of current normative principles.
- human tissue
- European regulation
- social control of science/technology
- informed consent
- policy guidelines/inst. review boards/review committees
- donation/procurement of organs/tissues
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Linked article 041632
Funding Tiss.EU project funded within the 7th Framework Program of the European Union (http://www.tisseu.org).
Competing interests None.
Provenance and peer review Commissioned; externally peer reviewed.
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries
- The human body as property? Possession, control and commodification
- Stored human tissue: an ethical perspective on the fate of anonymous, archival material
- The current approach of the courts
- Why does it matter how we regulate the use of human body parts?
- Reproductive and therapeutic cloning, germline therapy, and purchase of gametes and embryos: comments on Canadian legislation governing reproduction technologies
- Research involving storage and use of human tissue: how did the Human Tissue Act 2004 affect decisions by research ethics committees?
- Organoids as hybrids: ethical implications for the exchange of human tissues
- Human tissue legislation: listening to the professionals
- Ethics briefings